axicabtagene ciloleucel
daiichi sankyo,gilead
['cll', 'axi-cel', 'lymsm', 'kite pharma']
love a good real-world pro study, this one after axi-cel by et al. poster confirms transient worsening of qol after car with improvement over baseline by ~6 mos. look at the worsening financial toxicity (red line), though! cc #ash22 #lymsm #tcellrx 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????